Design Therapeutics Inc (DSGN)
R&D Expense Growth
13.97%
Quarterly · Period ending:
DSGN R&D Expense Growth
Latest reported13.97%period ending
Latest reported13.97%period ending
DSGN Quarterly R&D Growth (QoQ) (0.00% → 13.97%)
Latest values, visible window
High-resolution chart · PNG
DSGN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 13.9718% | |
| 7.1061% | |
| -7.9786% | |
| -7.3008% | |
| 2.3477% | |
| 26.4868% | |
| 2.3661% | |
| 14.5779% | |
| 7.3204% | |
| -12.2957% | |
| -16.9344% | |
| -22.3101% | |
| 8.4806% | |
| 10.3472% | |
| -0.3426% | |
| 26.6401% | |
| 28.9531% | |
| 19.3812% | |
| -14.0766% | |
| 69.8627% | |
| 29.729% | |
| 43.0945% | |
| 41.4838% | |
| 80.3959% | |
| 181.4324% | |
| 0% |